Innovent Biologics was among the investors in the oncology therapy developer’s oversubscribed round, which came as global investors are boosting their healthtech, biotech and wellness investment activities in China despite the country’s trade war with the US.

Airtable, HealthCare.com and T11 pull in nine-figure rounds.

Fintech and technology startups have continued to see their coffers grow

SoftBank helped e-commerce brand aggregator Merama hike its series B round to $285m while Koch Industries took part in a round valuing supply chain finance provider Tradeshift at $2.7bn.

Cerebral, Robotic Research, ABclonal Technology, Ola and RainMed Medical all pulled in nine-figure rounds, the first two featuring SoftBank Vision Fund 2.

Q&A with John Banta, president and managing director, Blue Venture Fund

The cancer diagnostics technology developer raised $300m from investors also including Kaiser Permanente, Intermountain, Novartis and Roche, but its machine learning model points to where GV is increasingly active.

Incode and Odyssey Therapeutics each secured over $200m while Alvotech Holdings, BenevolentAI and Tomorrow.io have agreed reverse mergers at unicorn valuations.

Professional education provider Platzi pulled in $60m through a Prosus-led round while e-commerce software producer Marketplacer took in $38m from investors including Salesforce Ventures.

SoftBank’s Latin America Fund helped prayer app developer Glorify raise $40m at a $250m valuation while decentralised derivatives network Hxro Network secured $34m in a round featuring several corporates.